Marketing itself as “your new best friend in fashion”, Cosette says it sources authentic designer bags at a discounted price from European suppliers by taking advantage of parallel importing ...

(Reuters) -An Australian court on Wednesday stopped U.S. drugmaker Cosette from abandoning its A$672 million ($437.6 million) takeover of Mayne Pharma, which now awaits clearance from the Foreign ...

Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion -- Experienced life sciences ...

BRIDGEWATER, N.J., December 16, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and Drug Administration ...

The two companies look to merge their women's health strengths to become a force in the field. (Yutthana Gaetgeaw/GettyImages) With a $430 million buyout of Australia’s Mayne Pharma locked down, ...

Cosette Pharmaceuticals had been trying to back out of its $430 million buyout of Mayne Pharma since May, prompting a legal back-and-forth between the two companies ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S.

BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary ...

— Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth — In this new role, David will oversee all ...